We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANDAs Linked to Semler Research Are Considered Invalid, FDA Says
ANDAs Linked to Semler Research Are Considered Invalid, FDA Says
Sponsors with pending ANDAs backed by trials conducted at India’s Semler Research Limited must return to the drawing board because of data integrity issues, the FDA said.